AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUMOS DIAGNOSTICS HOLDINGS L

0.025

+0.00313.64%

Volume:10.05M

Turnover:258.91K

Market Cap:18.71M

PE:-1.76

High:0.027

Open:0.022

Low:0.022

Close:0.022

Loading ...

Overview Company News Filings

Lumos Diagnostics to Receive Medicare Reimbursement for Test in Two US Regions; Shares Rise 14%

MT Newswires Live

Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop

Simply Wall St.

Lumos Diagnostics Holdings Agrees to Expand Scope of Work for Women's Health Test

MT Newswires Live

BRIEF-Lumos Diagnostics Posts HY Loss Attributable $2.8 Mln

Lumos Diagnostics - Hy Loss Attributable $2.8 Mln

THOMSON REUTERS

BRIEF-Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For Qtr

Lumos Diagnostics - Unaudited Revenue of US$2.9 Mln for Quarter

THOMSON REUTERS

Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too

Simply Wall St.

Lumos Diagnostics Partners With MedPro Associates for US National Contract Sales Coverage

MT Newswires Live

BRIEF-Lumos Diagnostics Partners With MedPro For Sales Of FebriDX In US

Lumos Diagnostics - Partners With Medpro for Sales of Febridx in US

THOMSON REUTERS

Lumos Expands Its 100% Fiber-Optic Internet to Stark County, Ohio With a Nearly $150M Investment

THOMSON REUTERS

3 ASX biotech shares rocketing 10% to 26% on BIG news!

Lumos Diagnostics Holdings Limited (ASX:LDX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Simply Wall St.

Favourable Signals For Lumos Diagnostics Holdings: Numerous Insiders Acquired Stock

Simply Wall St.

BRIEF-Lumos Diagnostics Posts Unaudited Revenue Of $3.4 Mln For Qtr

Lumos Diagnostics - Unaudited Revenue of US$3.4 Mln for Qtr

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LDX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.025,"timestamp":1744870320000,"preClose":0.022,"halted":0,"volume":10046021,"delay":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":359102273,"shares":748523022,"eps":-0.014203101862676332,"marketStatus":"Not Yet Opened","change":0.003,"latestTime":"04-17 16:12:00 AEST","open":0.022,"high":0.027,"low":0.022,"amount":258909,"amplitude":0.227273,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.014203101862676332,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":19.33098870551296,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":359102273,"roa":"-13.86%","roe":"-52.41%","lyrEps":-0.028913,"volumeRatio":19.33098870551296,"shares":748523022,"dividePrice":0,"high":0.027,"amplitude":0.227273,"preClose":0.022,"low":0.022,"week52Low":0.019,"pbRate":"1.23","psRate":"0.82","week52High":0.063,"institutionHeld":0,"latestPrice":0.025,"eps":-0.014203101862676332,"divideRate":0,"volume":10046021,"delay":0,"ttmEps":-0.014203101862676332,"open":0.022,"prevYearClose":0.035,"prevWeekClose":0.025,"prevMonthClose":0.024,"prevQuarterClose":0.024,"fiveDayClose":0.021,"twentyDayClose":0.023,"sixtyDayClose":0.043},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528753498","title":"Lumos Diagnostics to Receive Medicare Reimbursement for Test in Two US Regions; Shares Rise 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528753498","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528753498?lang=en_us&edition=fundamental","pubTime":"2025-04-17 13:38","pubTimestamp":1744868321,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  said it will start receiving Medicare reimbursement for its FebriDx rapid diagnostic test designed to distinguish bacterial from viral respiratory infections in two US regions, according to a Thursday filing with the Australian bourse.Effective this month, the test has been included in the Medicare fee schedule in the Palmetto and Novitas regions at a rate of $41.38 per test, the filing said.The test is reimbursable in both moderately complex and clinical laboratory improvement amendments waived settings, the company said.Shares of the company rose about 14% in recent Thursday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","RF","BK4211","LDX.AU","BK7126","BK4585"],"gpt_icon":0},{"id":"2517499140","title":"Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499140","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499140?lang=en_us&edition=fundamental","pubTime":"2025-03-08 04:54","pubTimestamp":1741380884,"startTime":"0","endTime":"0","summary":"To the annoyance of some shareholders, Lumos Diagnostics Holdings Limited ( ASX:LDX ) shares are down a considerable...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lacklustre-performance-is-driving-lumos-diagnostics-holdings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2516701935","title":"Lumos Diagnostics Holdings Agrees to Expand Scope of Work for Women's Health Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2516701935","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516701935?lang=en_us&edition=fundamental","pubTime":"2025-03-03 14:40","pubTimestamp":1740984034,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  and Hologic agreed to expand the scope of work for the new fetal fibronectin test, according to a Monday Australian bourse filing.The expanded scope of work relates to phase 3 of the development agreement, which focuses on delivery of the system prototype and will include the incorporation of additional hardware features into the proprietary reader technology.This is expected to generate additional fee revenue for Lumos of between $600,000 to $800,000.Phase 2 of the development agreement is expected to complete around April. The phase seeks to demonstrate that the assay can detect a biomarker.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2514381566","title":"BRIEF-Lumos Diagnostics Posts HY Loss Attributable $2.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381566?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:29","pubTimestamp":1740619740,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Posts HY Loss Attributable $2.8 MlnFeb 27 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:HY LOSS ATTRIBUTABLE $2.8 MILLIONHY REVENUES FROM ORDINARY ACTIVITIES $6.3 MILLIONFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2514898460","title":"Lumos Diagnostics -  Hy Loss Attributable $2.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898460?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:31","pubTimestamp":1740605507,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2507932730","title":"BRIEF-Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2507932730","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507932730?lang=en_us&edition=fundamental","pubTime":"2025-01-31 16:45","pubTimestamp":1738313105,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For QtrJan 31 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:UNAUDITED REVENUE OF US$2.9 MILLION FOR QUARTERFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OQ1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2507606409","title":"Lumos Diagnostics  - Unaudited Revenue of US$2.9 Mln for Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2507606409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507606409?lang=en_us&edition=fundamental","pubTime":"2025-01-31 06:02","pubTimestamp":1738274565,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2505933262","title":"Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too","url":"https://stock-news.laohu8.com/highlight/detail?id=2505933262","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505933262?lang=en_us&edition=fundamental","pubTime":"2025-01-21 04:01","pubTimestamp":1737403261,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings Limited ( ASX:LDX ) shareholders would be excited to see that the share price has had a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lumos-diagnostics-holdings-limiteds-asxldx-share-price-boost","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2503159343","title":"Lumos Diagnostics Partners With MedPro Associates for US National Contract Sales Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2503159343","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503159343?lang=en_us&edition=fundamental","pubTime":"2025-01-13 11:14","pubTimestamp":1736738076,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  partnered with MedPro Associates to provide national contract sales coverage for its point-of-care test, FebriDx, across hospital and primary care markets in the US, according to a Monday filing with the Australian bourse.MedPro will provide over 60 territory representatives to increase awareness and adoption of the FebriDx technology designed to differentiate between bacterial and non-bacterial infections, the filing said.Financial terms of the collaboration were not disclosed.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NHLD","LDX.AU"],"gpt_icon":0},{"id":"2503314399","title":"BRIEF-Lumos Diagnostics Partners With MedPro For Sales Of FebriDX In US","url":"https://stock-news.laohu8.com/highlight/detail?id=2503314399","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503314399?lang=en_us&edition=fundamental","pubTime":"2025-01-13 09:42","pubTimestamp":1736732520,"startTime":"0","endTime":"0","summary":"Jan 13 (Reuters) - Lumos Diagnostics Holdings Ltd :   * PARTNERS WITH MEDPRO FOR SALES OF FEBRIDX IN US Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2503397616","title":"Lumos Diagnostics - Partners With Medpro for Sales of Febridx in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2503397616","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503397616?lang=en_us&edition=fundamental","pubTime":"2025-01-13 06:25","pubTimestamp":1736720728,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250112:nFWN3O61DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2489528430","title":"Lumos Expands Its 100% Fiber-Optic Internet to Stark County, Ohio With a Nearly $150M Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2489528430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489528430?lang=en_us&edition=fundamental","pubTime":"2024-12-05 20:03","pubTimestamp":1733400239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nFWN3N60EX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2489288171","title":"3 ASX biotech shares rocketing 10% to 26% on BIG news!","url":"https://stock-news.laohu8.com/highlight/detail?id=2489288171","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489288171?lang=en_us&edition=fundamental","pubTime":"2024-12-05 09:28","pubTimestamp":1733362088,"startTime":"0","endTime":"0","summary":"Three ASX biotech shares are setting the bar high today. The companies have grabbed investor interest today, with each releasing promising news. And this is sending them racing ahead of the 0.2% gains","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/12/05/3-asx-biotech-shares-rocketing-10-to-26-on-big-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4588","BK7508","BK4208","LU1894683264.USD","BK7126","LU2637428348.USD","LU2346227817.USD","BK7067","LDX.AU","RAC.AU","BK4585","BK7124","BIG","BK4220","IIQ.AU","CMS","LU1894683348.USD","XAO.AU","BK4114"],"gpt_icon":0},{"id":"2486359827","title":"Lumos Diagnostics Holdings Limited (ASX:LDX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2486359827","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486359827?lang=en_us&edition=fundamental","pubTime":"2024-11-28 08:36","pubTimestamp":1732754217,"startTime":"0","endTime":"0","summary":"The Lumos Diagnostics Holdings Limited ( ASX:LDX ) share price has fared very poorly over the last month, falling by a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lumos-diagnostics-holdings-limited-asxldx-looks-inexpensive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2484987431","title":"Favourable Signals For Lumos Diagnostics Holdings: Numerous Insiders Acquired Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2484987431","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484987431?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:55","pubTimestamp":1731966919,"startTime":"0","endTime":"0","summary":"Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Lumos Diagnostics Holdings Limited , that sends out a positive message to the company's shareholders.Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.View our latest analysis for Lumos Diagnostics Holdings. The Last 12 Months Of Insider Transactions At Lumos Diagnostics Holdings. It is good to see recent purchasing. And the longer term insider transactions also give us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactio","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/favourable-signals-lumos-diagnostics-holdings-215519770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2479499212","title":"BRIEF-Lumos Diagnostics Posts Unaudited Revenue Of $3.4 Mln For Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2479499212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479499212?lang=en_us&edition=fundamental","pubTime":"2024-10-29 09:20","pubTimestamp":1730164825,"startTime":"0","endTime":"0","summary":"Oct 29 (Reuters) - Lumos Diagnostics Holdings Ltd :   * UNAUDITED REVENUE OF US$3.4 MILLION FOR QUARTERSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2479469054","title":"Lumos Diagnostics  - Unaudited Revenue of US$3.4 Mln for Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2479469054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479469054?lang=en_us&edition=fundamental","pubTime":"2024-10-29 06:27","pubTimestamp":1730154446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nFWN3M41QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null},{"market":"AU","date":"2023-08-30","symbol":"LDX.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1693317600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[]}}